ATI Comprehensive PN Pharmacology Exam Prep Document
| 2026/2027 Edition | 250 Verified Questions
ATI Comprehensive PN Pharmacology 2026-2027 QUESTIONS AND ANSWERS ALREADY GRADED A+. 100%
Verified Solutions | Updated Per Latest Guidelines | Graded A+
This comprehensive exam preparation document is meticulously designed for Practical Nursing (PN)
students preparing for the ATI Comprehensive Pharmacology exam. It contains 250 verified questions
that reflect the latest 2026/2027 academic year standards, ensuring alignment with current nursing
curricula and NCLEX-PN guidelines. Each question is accompanied by a detailed rationale and correct
answer, providing a robust review of essential pharmacological concepts. This resource is an
indispensable tool for achieving a high score and demonstrating clinical competence in pharmacology.
Key Features:
Pharmacokinetics and pharmacodynamics
Medication administration and safety
Drug classifications and therapeutic uses
Adverse effects and contraindications
Nursing interventions and patient education
Dosage calculations and conversions
Updates for 2026:
- Incorporates 2026-2027 ATI test plan updates
- Includes new questions on recently approved medications
- Expanded rationales for enhanced understanding
- Aligned with latest NCLEX-PN test blueprint
- Enhanced coverage of safety and quality improvement
Abstract:
The ATI Comprehensive PN Pharmacology Exam Prep Document is a scholarly compilation of 250 verified
questions and answers, meticulously curated for the 2026/2027 academic year. This resource is grounded in
evidence-based practice and aligned with the National Council Licensure Examination for Practical Nurses
(NCLEX-PN) and ATI testing standards. It provides a systematic review of pharmacological principles, including
drug classifications, mechanisms of action, therapeutic uses, adverse effects, and nursing considerations. Each
question is designed to assess critical thinking and clinical judgment, with detailed rationales that explain both
correct and incorrect options. The document also emphasizes medication safety, dosage calculations, and patient
education, ensuring comprehensive preparation. This exam prep is an essential tool for practical nursing students
seeking to excel in their pharmacology coursework and licensure examinations.
Keywords:
ATI Pharmacology, PN Pharmacology, NCLEX-PN, Pharmacology Exam Prep, Nursing Pharmacology,
Medication Safety, Drug Calculations
Answer Format:
Each question is presented in multiple-choice format with four options. The correct answer is clearly indicated,
followed by a comprehensive rationale explaining why it is correct and why the other options are incorrect.
Rationales include relevant pharmacological concepts, nursing implications, and clinical pearls to reinforce
learning.
Compliance Checklist:
Aligned with 2026-2027 ATI and NCLEX-PN standards
Page 1
, Verified questions with evidence-based rationales
Updated to reflect current pharmacological guidelines
Suitable for self-assessment and exam review
Includes dosage calculation and safety scenarios
Content Area Overview:
Content Area Questions Key Topics Weight
Pharmacokinetics and 1-50 Absorption, Distribution, Metabolism, 20%
Pharmacodynamics Excretion, Receptor interactions
Medication Administration and 51-100 Routes, Rights of administration, Error 20%
Safety prevention, High-alert medications
Drug Classifications and 101-150 Antibiotics, Analgesics, Cardiovascular, 20%
Therapeutic Uses Endocrine, Psychotropic
Adverse Effects and 151-200 Side effects, Toxicities, Drug interactions, 20%
Contraindications Allergic reactions
Nursing Interventions and 201-250 Monitoring, Patient teaching, Lifestyle 20%
Patient Education modifications, Follow-up care
Page 2
,Q1. A patient with type 2 diabetes is prescribed metformin 500 mg twice daily. The
nurse reviews laboratory results: eGFR 40 mL/min/1.73 m², serum creatinine 1.8
mg/dL. Which action is most appropriate?
A. Administer the dose as prescribed.
B. Hold the dose and notify the provider.
C. Reduce the dose to 250 mg.
D. Increase fluid intake and continue.
Correct Answer: B. Hold the dose and notify the provider.
Rationale: Metformin is contraindicated when eGFR is below 30 mL/min/1.73 m², and
dose reduction is recommended when eGFR is 30-45. An eGFR of 40 indicates the need
for dose adjustment, but holding and notifying the provider is safest because the
prescribed dose is too high. Continuing or reducing without provider order is unsafe.
Why Wrong:
A - Administering the full dose risks lactic acidosis due to reduced renal clearance.
C - Dose reduction requires a provider order; the nurse cannot independently change
the dose.
D - Increasing fluid intake does not address the contraindication and may cause fluid
overload.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 49
Q2. A patient on warfarin has an INR of 5.8 and no signs of bleeding. The provider
orders vitamin K 2.5 mg orally. Which nursing consideration is most important?
A. Administer the vitamin K with food to enhance absorption.
B. Monitor for anaphylaxis after administration.
C. Evaluate the patient's dietary vitamin K intake.
D. Recheck INR in 24 hours to assess response.
Correct Answer: D. Recheck INR in 24 hours to assess response.
Rationale: The goal of vitamin K administration is to lower INR to a therapeutic range.
Rechecking INR in 24 hours is essential to evaluate effectiveness and guide further dosing.
Oral vitamin K is well absorbed, anaphylaxis is rare, and dietary intake is not the
immediate concern.
Why Wrong:
A - Vitamin K absorption is not significantly affected by food; this is not the most
important consideration.
B - Anaphylaxis is extremely rare with oral vitamin K; not a priority.
C - While dietary vitamin K affects INR, it is not the immediate priority in this acute
situation.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 33
Page 3
, Q3. Which drug is most likely to cause a lupus-like syndrome with prolonged use?
A. Hydralazine
B. Lisinopril
C. Amlodipine
D. Losartan
Correct Answer: A. Hydralazine
Rationale: Hydralazine is a vasodilator known to induce a lupus-like syndrome, especially
in slow acetylators. ACE inhibitors, calcium channel blockers, and ARBs are not typically
associated with this adverse effect.
Why Wrong:
B - Lisinopril is associated with cough and angioedema, not lupus-like syndrome.
C - Amlodipine causes peripheral edema, not lupus-like syndrome.
D - Losartan may cause hyperkalemia, but not lupus-like syndrome.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 24
Q4. A patient receiving IV heparin develops a sudden drop in platelet count from
200,000 to 90,000/mm³. Which antibody is most likely responsible?
A. Anti-PF4-heparin IgG
B. Anti-GPIIb/IIIa
C. Anti-vWF
D. Anti-thrombin III
Correct Answer: A. Anti-PF4-heparin IgG
Rationale: Heparin-induced thrombocytopenia (HIT) is caused by antibodies against the
platelet factor 4 (PF4)-heparin complex, leading to platelet activation and thrombosis.
Anti-GPIIb/IIIa antibodies are seen in immune thrombocytopenia, not HIT.
Why Wrong:
B - Anti-GPIIb/IIIa antibodies are associated with ITP, not HIT.
C - Anti-vWF antibodies are not typical in HIT.
D - Anti-thrombin III antibodies are not involved in HIT.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 34
Q5. A patient with severe hypertension is started on nitroprusside. What is the most
critical nursing assessment during administration?
A. Monitor for cyanide toxicity
B. Monitor for hyperkalemia
C. Monitor for bradycardia
D. Monitor for hyperglycemia
Correct Answer: A. Monitor for cyanide toxicity
Page 4
| 2026/2027 Edition | 250 Verified Questions
ATI Comprehensive PN Pharmacology 2026-2027 QUESTIONS AND ANSWERS ALREADY GRADED A+. 100%
Verified Solutions | Updated Per Latest Guidelines | Graded A+
This comprehensive exam preparation document is meticulously designed for Practical Nursing (PN)
students preparing for the ATI Comprehensive Pharmacology exam. It contains 250 verified questions
that reflect the latest 2026/2027 academic year standards, ensuring alignment with current nursing
curricula and NCLEX-PN guidelines. Each question is accompanied by a detailed rationale and correct
answer, providing a robust review of essential pharmacological concepts. This resource is an
indispensable tool for achieving a high score and demonstrating clinical competence in pharmacology.
Key Features:
Pharmacokinetics and pharmacodynamics
Medication administration and safety
Drug classifications and therapeutic uses
Adverse effects and contraindications
Nursing interventions and patient education
Dosage calculations and conversions
Updates for 2026:
- Incorporates 2026-2027 ATI test plan updates
- Includes new questions on recently approved medications
- Expanded rationales for enhanced understanding
- Aligned with latest NCLEX-PN test blueprint
- Enhanced coverage of safety and quality improvement
Abstract:
The ATI Comprehensive PN Pharmacology Exam Prep Document is a scholarly compilation of 250 verified
questions and answers, meticulously curated for the 2026/2027 academic year. This resource is grounded in
evidence-based practice and aligned with the National Council Licensure Examination for Practical Nurses
(NCLEX-PN) and ATI testing standards. It provides a systematic review of pharmacological principles, including
drug classifications, mechanisms of action, therapeutic uses, adverse effects, and nursing considerations. Each
question is designed to assess critical thinking and clinical judgment, with detailed rationales that explain both
correct and incorrect options. The document also emphasizes medication safety, dosage calculations, and patient
education, ensuring comprehensive preparation. This exam prep is an essential tool for practical nursing students
seeking to excel in their pharmacology coursework and licensure examinations.
Keywords:
ATI Pharmacology, PN Pharmacology, NCLEX-PN, Pharmacology Exam Prep, Nursing Pharmacology,
Medication Safety, Drug Calculations
Answer Format:
Each question is presented in multiple-choice format with four options. The correct answer is clearly indicated,
followed by a comprehensive rationale explaining why it is correct and why the other options are incorrect.
Rationales include relevant pharmacological concepts, nursing implications, and clinical pearls to reinforce
learning.
Compliance Checklist:
Aligned with 2026-2027 ATI and NCLEX-PN standards
Page 1
, Verified questions with evidence-based rationales
Updated to reflect current pharmacological guidelines
Suitable for self-assessment and exam review
Includes dosage calculation and safety scenarios
Content Area Overview:
Content Area Questions Key Topics Weight
Pharmacokinetics and 1-50 Absorption, Distribution, Metabolism, 20%
Pharmacodynamics Excretion, Receptor interactions
Medication Administration and 51-100 Routes, Rights of administration, Error 20%
Safety prevention, High-alert medications
Drug Classifications and 101-150 Antibiotics, Analgesics, Cardiovascular, 20%
Therapeutic Uses Endocrine, Psychotropic
Adverse Effects and 151-200 Side effects, Toxicities, Drug interactions, 20%
Contraindications Allergic reactions
Nursing Interventions and 201-250 Monitoring, Patient teaching, Lifestyle 20%
Patient Education modifications, Follow-up care
Page 2
,Q1. A patient with type 2 diabetes is prescribed metformin 500 mg twice daily. The
nurse reviews laboratory results: eGFR 40 mL/min/1.73 m², serum creatinine 1.8
mg/dL. Which action is most appropriate?
A. Administer the dose as prescribed.
B. Hold the dose and notify the provider.
C. Reduce the dose to 250 mg.
D. Increase fluid intake and continue.
Correct Answer: B. Hold the dose and notify the provider.
Rationale: Metformin is contraindicated when eGFR is below 30 mL/min/1.73 m², and
dose reduction is recommended when eGFR is 30-45. An eGFR of 40 indicates the need
for dose adjustment, but holding and notifying the provider is safest because the
prescribed dose is too high. Continuing or reducing without provider order is unsafe.
Why Wrong:
A - Administering the full dose risks lactic acidosis due to reduced renal clearance.
C - Dose reduction requires a provider order; the nurse cannot independently change
the dose.
D - Increasing fluid intake does not address the contraindication and may cause fluid
overload.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 49
Q2. A patient on warfarin has an INR of 5.8 and no signs of bleeding. The provider
orders vitamin K 2.5 mg orally. Which nursing consideration is most important?
A. Administer the vitamin K with food to enhance absorption.
B. Monitor for anaphylaxis after administration.
C. Evaluate the patient's dietary vitamin K intake.
D. Recheck INR in 24 hours to assess response.
Correct Answer: D. Recheck INR in 24 hours to assess response.
Rationale: The goal of vitamin K administration is to lower INR to a therapeutic range.
Rechecking INR in 24 hours is essential to evaluate effectiveness and guide further dosing.
Oral vitamin K is well absorbed, anaphylaxis is rare, and dietary intake is not the
immediate concern.
Why Wrong:
A - Vitamin K absorption is not significantly affected by food; this is not the most
important consideration.
B - Anaphylaxis is extremely rare with oral vitamin K; not a priority.
C - While dietary vitamin K affects INR, it is not the immediate priority in this acute
situation.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 33
Page 3
, Q3. Which drug is most likely to cause a lupus-like syndrome with prolonged use?
A. Hydralazine
B. Lisinopril
C. Amlodipine
D. Losartan
Correct Answer: A. Hydralazine
Rationale: Hydralazine is a vasodilator known to induce a lupus-like syndrome, especially
in slow acetylators. ACE inhibitors, calcium channel blockers, and ARBs are not typically
associated with this adverse effect.
Why Wrong:
B - Lisinopril is associated with cough and angioedema, not lupus-like syndrome.
C - Amlodipine causes peripheral edema, not lupus-like syndrome.
D - Losartan may cause hyperkalemia, but not lupus-like syndrome.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 24
Q4. A patient receiving IV heparin develops a sudden drop in platelet count from
200,000 to 90,000/mm³. Which antibody is most likely responsible?
A. Anti-PF4-heparin IgG
B. Anti-GPIIb/IIIa
C. Anti-vWF
D. Anti-thrombin III
Correct Answer: A. Anti-PF4-heparin IgG
Rationale: Heparin-induced thrombocytopenia (HIT) is caused by antibodies against the
platelet factor 4 (PF4)-heparin complex, leading to platelet activation and thrombosis.
Anti-GPIIb/IIIa antibodies are seen in immune thrombocytopenia, not HIT.
Why Wrong:
B - Anti-GPIIb/IIIa antibodies are associated with ITP, not HIT.
C - Anti-vWF antibodies are not typical in HIT.
D - Anti-thrombin III antibodies are not involved in HIT.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 34
Q5. A patient with severe hypertension is started on nitroprusside. What is the most
critical nursing assessment during administration?
A. Monitor for cyanide toxicity
B. Monitor for hyperkalemia
C. Monitor for bradycardia
D. Monitor for hyperglycemia
Correct Answer: A. Monitor for cyanide toxicity
Page 4
